Biophotons: How Your Cells Use Light to Communicate

Every Cell Emits Light

Picture a neuroscientist sitting alone in a laboratory at three in the morning, watching a photomultiplier tube register signals from a preparation of rat brain tissue submerged in a darkened chamber. The electrical activity is well understood, mapped to the millisecond by decades of electrophysiology. But the photomultiplier is registering something else entirely: faint, sporadic pulses of light, emanating from the tissue itself, without any external source. The equipment is sensitive enough to detect individual photons. The chamber is shielded inside a Faraday cage and wrapped in multiple layers of light-blocking material. And still, photons arrive. Not many, certainly not enough to see with the naked eye, but enough to count, to characterize, and increasingly, to take seriously.

This is not a scene from science fiction. It is a condensed version of the experimental reality that has occupied a growing number of biophysicists for the better part of five decades. The phenomenon in question is called ultraweak photon emission, or UPE, and the particles involved are known as biophotons. Every living cell in your body produces them. Your skin emits them right now, at levels far too dim to perceive but measurable with the right instrumentation. Your neurons emit them during signaling. Your metabolizing liver cells emit them. Even plant cells emit them. The question that has occupied researchers since the 1970s is not whether these emissions exist; modern instrumentation has settled that beyond reasonable doubt. The question is what, if anything, they mean for biology.

That question sits at the intersection of biophysics, neuroscience, and the emerging field of quantum medicine, where researchers are beginning to take seriously the possibility that quantum-scale phenomena play functional roles in living systems. Biophotons may be the most tangible and measurable of those phenomena, which makes them both a compelling research target and a subject prone to exaggeration. To understand what the science actually says, you need to follow the light back to its source.

What Biophotons Are and Are Not

Biophotons are photons of visible and near-infrared light, typically in the range of 200 to 1000 nanometers, that are produced spontaneously by living organisms as a byproduct of metabolic chemistry. They are not the same as bioluminescence, the relatively bright light produced by organisms such as fireflies or deep-sea jellyfish, which involves dedicated enzymatic machinery evolved specifically to generate light. Biophotons are far weaker, orders of magnitude fainter than bioluminescent signals, and they arise as incidental byproducts of ordinary cellular chemistry rather than as the products of a specialized light-producing pathway.

The primary source of biophotons is reactive oxygen species, or ROS: chemically reactive molecules such as superoxide radicals, hydrogen peroxide, and singlet oxygen that arise as natural byproducts of aerobic metabolism. When two ROS molecules react with each other in a process called chemiluminescence, or when electronically excited molecules relax back to their ground state following metabolic reactions, photons are released. The process is thermodynamically unavoidable given the chemistry of oxygen-based energy production. Because virtually every aerobic cell undergoes these reactions continuously, virtually every aerobic cell emits a trickle of light. Researchers estimate typical emission rates fall somewhere between 10 and 1000 photons per second per square centimeter of tissue surface, though the precise figures vary considerably depending on tissue type, metabolic state, and measurement conditions.

It is important to be clear about what this does not mean. Biophotons are not proof that the body runs on light, not a validation of therapeutic laser claims that lack clinical evidence, and not evidence for any metaphysical concept of an energy body or aura. The wellness industry has been quick to appropriate the language of biophotons to lend scientific credibility to claims that go well beyond what the research supports. The actual science is both more modest and, in its own way, more interesting than those appropriations suggest.

Fritz-Albert Popp and the Discovery

The scientist most closely associated with bringing biophoton research to serious academic attention is Fritz-Albert Popp, a German biophysicist who began his investigations in the 1970s while working at the University of Marburg. Popp's original interest was not in cell communication at all but in the physics of carcinogenesis. He was investigating the molecular mechanisms by which polycyclic aromatic hydrocarbons cause cancer, and he noticed a peculiar pattern: the most potently carcinogenic compounds in a series he was studying were also the most efficient absorbers and re-emitters of ultraviolet light. This observation led him to speculate that the capacity to interact with light at the molecular level might be mechanistically relevant to cancer initiation.

From that starting point, Popp began investigating the light-emitting properties of biological systems more broadly. Working with increasingly sensitive photomultiplier equipment over the following decade, he and his collaborators demonstrated that all living organisms emit ultraweak light continuously, that the emission is coherent in the optical physics sense of the word, meaning the photons show statistical properties more consistent with laser-like coherence than with random thermal emission, and that the emission patterns change in measurable ways in response to physiological perturbations including stress, disease, and chemical exposure. Popp published his findings in a series of papers beginning in the late 1970s and eventually established the International Institute of Biophysics in Neuss, Germany, which became a coordinating center for biophoton research across multiple countries.

Popp's coherence claim has been the most controversial aspect of his work. The idea that biophotons exhibit optical coherence, a property associated with laser light and quantum optical systems, would imply that the photon field inside a living cell is far more organized than a simple byproduct of metabolic noise would be. It would suggest, at minimum, that living systems maintain some form of quantum optical order, and it would open the door to the hypothesis that photons could serve as information carriers within and between cells. The coherence claim has not been universally accepted; some researchers argue that the statistical analyses used to demonstrate it are methodologically ambiguous, and replication has been inconsistent. But it has never been definitively refuted, and it continues to motivate experimental work in biophysics laboratories worldwide.

Communication Hypothesis: Signal or Noise?

The most ambitious version of the biophoton hypothesis holds that cells use photon emissions as a genuine signaling channel, transmitting information between cells and tissues in a way that complements or supplements the electrochemical signaling pathways that conventional biology has characterized. This hypothesis requires several things to be true simultaneously: that emissions are not purely random noise, that they carry information that can be decoded by recipient cells, that cells possess some mechanism for detecting incoming photons against the background of ambient light, and that this detection influences cell behavior in measurable ways.

Evidence for each of these requirements exists, though none of it is airtight. Studies have shown that biophoton emission is not purely random in its timing statistics. Popp's group and others have reported that emission follows patterns consistent with deterministic chaos rather than simple thermal noise, which would be consistent with biological regulation. Cell-to-cell communication via photons has been studied in several experimental systems. Research groups have reported that separating two populations of cells by a quartz window, which transmits ultraviolet and visible light, allows them to influence each other's behavior in ways that separation by a glass window, which blocks UV, does not. This kind of experiment suggests that UV photons carry a biologically relevant signal, though critics have argued that the effect sizes are small and the controls imperfect.

The mechanism by which a cell would detect incoming biophotons presents a genuine theoretical challenge. Cell membranes and cytoplasm are not obviously optimized as photodetectors. However, several proteins are known to be photosensitive even outside of visual systems; cryptochrome proteins, for instance, which are found in virtually all eukaryotes and play roles in circadian rhythmicity, are sensitive to blue light and may represent one avenue through which cells could register photon signals. This connects to the broader question of quantum mechanical effects in biological systems, where researchers have found that quantum phenomena appear in places that classical biology did not expect them. The story of how quantum coherence was discovered to play a role in photosynthetic energy transfer offers an instructive parallel: for decades the idea seemed implausible, and then experimental evidence made it impossible to ignore. You can read more about that case in our examination of quantum coherence in photosynthesis.

Neurons and Light: The Brain Connection

Of all the tissues that have been investigated for biophoton emission, the nervous system presents perhaps the most tantalizing implications. The brain is already known to be an extraordinarily dense site of metabolic activity, consuming roughly 20 percent of the body's energy budget despite representing only about 2 percent of its mass. Given that biophoton emission scales with metabolic activity and with ROS production, the brain would be expected to be a bright source of ultraweak light by the standards of the field. That expectation has been confirmed experimentally. More provocative is the question of whether neural biophoton emission plays any role in information processing.

Jiapei Dai, a neuroscientist at the Wuhan Institute of Neuroscience and Neuroengineering in China, has been among the most active investigators of neural biophotons in recent years. Dai and his colleagues published a significant study in 2011 in PLOS ONE demonstrating that rat neural tissue emits biophotons during neural activity, that the emission intensity correlates with the degree of neural firing, and that the emissions propagate along neural axons. The propagation finding was particularly striking: it suggested that photons might travel within the nervous system in a way that parallels, or at least accompanies, electrical signal propagation. If confirmed and extended, this would imply that the nervous system has an optical channel running in parallel with its electrochemical one.

Theoretical work by Anirban Bandyopadhyay at the National Institute for Materials Science in Tsukuba, Japan, and by Christof Koch and others working on the neural correlates of consciousness, has raised the possibility that photon-based signaling in the brain could contribute to neural synchronization: the coordinated oscillatory activity of neural populations that is associated with cognitive functions including attention, memory consolidation, and conscious awareness. This remains speculative, and the theoretical frameworks involved are contested. But the experimental foundation provided by Dai's work and others has given the speculation a grounding that purely theoretical proposals lack.

One mechanism proposed for optical signal transmission within neurons involves the myelinated axons themselves. Myelin, the fatty sheath that insulates many axons and dramatically speeds electrical conduction, has optical properties that may allow it to act as a waveguide for photons. Opaque at visible wavelengths but partially transmissive in certain wavelength ranges, myelin could in principle channel biophotons along the length of an axon, much as an optical fiber channels laser light. This proposal, advanced by researchers including Jack Tuszynski at the University of Alberta, remains to be tested directly, but it represents the kind of testable mechanistic hypothesis that moves a research area from speculation toward experiment.

Cancer Diagnostics and Altered Emission Patterns

One of the most practically consequential lines of biophoton research concerns the possibility that malignant cells emit light differently from healthy ones. Fritz-Albert Popp himself noted in his early work that cancer cells appeared to emit more photons than adjacent normal tissue, and that the emission from cancer cells showed less of the organized coherence he associated with healthy biological systems. The idea was that healthy cells maintain a kind of photonic order, a regulated, coherent emission pattern, and that cancer disrupts this order in ways that are detectable.

Subsequent experimental work has provided some support for altered emission in cancer, though the picture is complicated. Researchers have reported differences in biophoton emission between cancerous and normal tissue in a variety of experimental models, including studies of human tumor samples and animal models of carcinogenesis. The alterations include both changes in total emission intensity and changes in the temporal statistics of emission, consistent with the idea that cancer disrupts whatever regulatory mechanisms normally constrain the photon field in healthy tissue. A 2014 study published in the Journal of Photochemistry and Photobiology found measurable differences in UPE patterns between normal and cancerous human breast tissue, pointing toward the possibility of a non-invasive optical diagnostic tool.

The diagnostic potential is appealing for obvious reasons: a non-invasive, surface measurement technique that could indicate metabolic abnormalities in underlying tissue would be valuable in cancer screening and monitoring. However, the specificity and sensitivity of biophoton measurements as diagnostic tools have not yet been established at the level required for clinical use. The technical challenges of standardizing measurements across different instruments, subjects, and environmental conditions are substantial, and the field has not yet produced the large-scale clinical studies that would be needed to validate a biophoton-based diagnostic approach. This is an area of active investigation rather than established clinical practice, and anyone who suggests otherwise is moving ahead of the evidence.

How to Separate Science From Pseudoscience

Biophoton research occupies an uncomfortable position in the scientific landscape: it is sufficiently unusual and sufficiently associated with fringe claims that many mainstream biologists have been reluctant to engage with it seriously, yet the core experimental finding of ultraweak photon emission from living organisms is reproducible, instrumentally well-characterized, and published in peer-reviewed journals including PLOS ONE, the Journal of Photochemistry and Photobiology, and other respectable venues. The challenge for any interested reader is to distinguish the credible science from the considerable volume of pseudoscientific material that uses biophoton language to dress up claims that have no experimental support.

A few heuristics are useful here. First, credible biophoton research specifies its measurement methods in detail: the type of photomultiplier tube used, the shielding conditions, the calibration procedures, the statistical analysis applied to the emission data. Papers that do not provide this level of methodological transparency should be treated with skepticism. Second, credible claims about biophoton communication or information transfer are accompanied by proposed mechanisms: specific molecular receptors, characterized signal pathways, testable predictions. Claims that invoke biophotons as a general explanation for poorly understood biological phenomena, without identifying a mechanism, are not scientific hypotheses; they are placeholder explanations.

Third, and perhaps most importantly, credible biophoton research is cautious about the gap between what has been measured and what has been inferred. The fact that neurons emit photons during activity, for instance, does not by itself establish that those photons carry information. It establishes a correlation between metabolic activity and photon emission, which is mechanistically expected given what we know about ROS chemistry. The additional claim that photons serve a signaling function requires additional evidence: direct demonstrations of photon-mediated cell-to-cell effects, characterization of cellular photoreception, evidence that blocking photon transmission alters the outcome of a biological process in a predictable way. Some of that evidence is beginning to emerge, but the field has not yet reached the standard required to declare the communication hypothesis confirmed.

What makes biophoton research worth following, despite its unresolved questions, is the pattern it fits into. Over the past two decades, biology has repeatedly discovered that quantum-scale phenomena are at work in processes that classical models had assumed to be purely thermal and classical: proton tunneling in enzyme catalysis, quantum coherence in photosynthetic energy transfer, radical pair mechanisms in avian magnetic navigation. In each case, the initial proposal seemed implausible to mainstream biology, and in each case careful experiment vindicated the basic phenomenon, even as debates continued about the precise mechanisms and biological significance. Biophotons may follow a similar trajectory. The ultraweak light your cells are producing right now may be noise, may be an unintended byproduct of chemistry that serves no function at all. Or it may be one component of a cellular communication system that biology has overlooked for a century because it lacked the tools to measure it. Deciding which of those possibilities is closer to the truth is, at this point, a matter of ongoing experiment rather than settled science, and that is precisely what makes it worth watching.

The broader context for this research sits squarely within the questions that drive the field of quantum biology: to what extent do living systems exploit quantum mechanical effects in ways that confer functional advantages, and what would it mean for medicine if they do? These are the questions that motivated the development of quantum medicine as a research discipline, and biophoton research represents one of its most accessible experimental entry points. The light is real. Whether it speaks is the question that the next decade of research will have to answer.